6 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
News 2026-09-21 20:10 UTC
Curium US Holdings plans to acquire Lantheus through a merger, leaving Lantheus as a wholly owned subsidiary. Curium withdrew its merger filing on Sept. 17 to give regulators more review time, then refiled on Sept. 21. The reset 30-day review period runs to Oct. 21, 2026, unless it ends early or is extended. The deal i
News 2026-08-04 12:05 UTC
Lantheus Holdings merges with Curium at $102.50 plus CVR
News 2026-08-03 12:26 UTC
Supernus and Indivior merge to create CNS biopharmaceutical leader
News 2026-08-03 11:34 UTC
LNTH Curium Announces Definitive Agreement to Merge with Lantheus. Curium to acquire Lantheus for $102.50/share in cash, plus CVR for up to $12/share
News 2026-08-03 11:31 UTC
Curium merges with Lantheus in $8B deal
News 2026-08-03 11:31 UTC
Lantheus merging with Curium